Press Releases

Varian and Cincinnati Children's Hospital Medical Center/University of Cincinnati Medical Center Proton Therapy Center Achieve Significant Milestone in Research of FLASH Therapy

Varian (NYSE: VAR) in collaboration with Cincinnati Children's Hospital Medical Center/University of Cincinnati Medical Center Proton Therapy Center announced the achievement of a significant...

Varian and Cincinnati Children's Hospital Medical Center/University of Cincinnati Medical Center Proton Therapy Center Achieve Significant Milestone in Research of FLASH Therapy

Varian (NYSE: VAR) in collaboration with Cincinnati Children's Hospital Medical Center/University of Cincinnati Medical Center Proton Therapy Center announced the achievement of a significant...

Varian Highlights Interventional Oncology Solutions at CIO Symposium

Varian (NYSE: VAR) will showcase the company's interventional oncology solutions at the Symposium on Clinical Interventional Oncology, October 11-13, 2019 in Miami, Fla. The Varian interventional...

Varian U.S. Tariff Exclusion Request Granted for Radiotherapy System Components

Varian (NYSE: VAR) today announced the United States Trade Representative (USTR) has granted exclusion of components sourced from China for linear accelerators manufactured in the U.S from Section...

Varian Ranked Highest in Survey of US Radiation Oncology Professionals

Varian (NYSE: VAR) has been recognized again as a leader in the annual IMV ServiceTrak™ Radiation Oncology Systems report, ranking first in eight of the tracked categories. Additionally,...

Varian Announces Multi-room Configuration for ProBeam 360 Proton Therapy System

Varian (NYSE: VAR) today announced its ProBeam 360° proton therapy system is now available in a multi-room configuration. The ProBeam 360° system is the smallest multi-room system available for...

Varian Names Chief Medical Officer for Interventional Oncology

Varian (NYSE: VAR) has named Francis R. Facchini, M.D., FSIR, as the new chief medical officer, Interventional Oncology, reporting to Dee Khuntia, Varian chief medical officer. Effective September...

Varian Unveils Innovative New Solution for Adaptive Therapy

Strengthening its leadership in delivering innovative new solutions to transform cancer care globally, Varian (NYSE: VAR) today announced Ethos™ therapy, an Adaptive Intelligence™ solution....

Varian and Oncora Partner to Accelerate Precision Medicine in Radiation Oncology

Varian (NYSE: VAR) today announced it is investing in Oncora Medical and partnering to accelerate the development of software tools to enable precision medicine in radiation oncology. Oncora is a...

Varian Announces Fourth Quarter Fiscal Year 2019 Earnings Release Date

Varian (NYSE: VAR) today announced its fourth quarter fiscal year 2019 earnings release date. The Company will report results for the fourth quarter of fiscal year 2019 after market close on...